Isoforms of murine and human serum amyloid P component

Scandinavian Journal of Immunology

Volumn 48, Issue 4, 1998, Pages 350-356

  Nybo, M ^a   Hackler, R ^b   Kold, B ^a   Holm Nielsen, E ^a   Steinmetz, A ^b   Svehag, S E ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; SERUM AMYLOID P; SIALIDASE; UREA;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD SAMPLING; ENZYME ACTIVITY; HUMAN; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM; STRAIN DIFFERENCE;

ANIMALS; HUMANS; ISOELECTRIC FOCUSING; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; PROTEIN ISOFORMS; SERUM AMYLOID P-COMPONENT;

EID: 0031721796     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00404.x     Document Type: Article

References (31)

1. Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 1979;38:284-93.
2. Pepys MB, Butler PJG. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun 1987;148:308-13.
3. Hamazaki H. Calcium-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate. J Biol Chem 1987;262:1456-60.
4. 2+-dependent binding of human serum amyloid P component to Alzheimer's β-amyloid peptide. J Biol Chem 1995; 270:10392-4.
5. Juul Sørensen I, Holm Nielsen E, Andersen O, Danielsen B, Svehag SE. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase. Scand J Immunol 1996;44:401-7.
6. Danielsen B, Juul Sørensen I, Nybo M, Holm Nielsen E, Kaplan B, Svehag SE. Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH. Biochim Biophys Acta 1997;339:73-8.
7. Pepys MB, Baltz ML, de Beer FC et al. Biology of serum amyloid P component. Ann NY Acad Sci 1982;389:286-97.
8. Coria F, Castano E, Prelli F et al. Isolation and characterisation of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 1988;58:454-8.
9. Duong T, Pommier EC, Scheibel AB. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 1989;78:429-37.
10. Pepys MB, Baltz ML, Gomer K, Davies AJS, Doenhoff M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 1979;278:259-61.
11. Baltz ML, Gomer K, Davies AJS, Evans DJ, Klaus GGB, Pepys MB. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Clin Exp Immunol 1980;39:355-60.
12. Mortensen RF, Beisel K, Zeleznik NJ, Phong TL. Acute phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol 1983;130:885-9.
13. Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E. Amyloid P component. A critical review. Amyloid: Int J Exp Clin Invest 1997;4:274-95.
14. Baltz, ML, de Beer FC, Feinstein A et al. Phylogenetic aspects of C-reactive protein and related proteins. Ann NY Acad Sci 1982; 389:49-75.
15. Pepys MB, Rademacher TW, Amatayakul-Chantler S et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 1994;91:5602-6.
16. Hawkins PN, Tennent GA, Woo P, Pepys MB. Studies in vivo and in vitro of human serum amyloid P component in normals and in a patient with AA amyloidosis. Clin Exp Immunol 1991;84:308-16.
17. Emsley J, White HE, O'Hara BP et al. Structure of pentameric human serum amyloid P component. Nature 1994;367:338-45.
18. Juul Sørensen I, Andersen O, Holm Nielsen E, Svehag SE. Multiple isoforms of the human pentraxin serum amyloid P component. Int Arch Allergy Immunol 1995;106:25-31.
19. Kubak BM, Gewurz H, Potempa LA. Identification of multiple forms of the P component of amyloid isolated from human serum. Int Arch Allergy Appl Immunol 1988;87:194-203.
20. Dhawan S, Fields RL, Robey FA. A novel peptide from amyloid P component supports cell attachment. Biochim Biophys Acta 1990;171:1284-90.
21. Andersen O, Friis P, Holm Nielsen E, Vilsgaard K, Leslie RGQ, Svehag SE. Purification, subunit characterization and ultrastructure of three soluble bovine lectins: conglutinin, mannose-binding protein and the pentraxin serum amyloid P-component. Scand J Immunol 1992;36:131-41.
22. Hackler R, Arndt T, Kleine TO, Gressner AM. Effect of separation conditions on automated isoelectric focusing of carbohydrate-deficient transferrin and other human isotransferrins using the PhastSystem. Anal Biochem 1995;230:281-9.
23. Esen A. A simple method for casting polyacrylamide gels of varying thickness and size for flat-bed isoelectric focusing. In: Allen RC, Arnaud P, eds Electrophoresis '81. Advanced methods, biochemical and clinical applications. Berlin, New York: Walter de Gruyter & Co., 1981:73-6.
24. Storgaard P. Purification and characterization of C-type lectins that contain a collagen-like domain, with special reference to porcine lectins [in Danish]. MSc thesis 1994, Odense University, Denmark.
25. Altland K, Rauh S, Hackler R. Demonstration of human prealbumin by double one-dimensional slab gel electrophoresis. Electrophoresis 1982;2:148-55.
26. Hackler R, Schäfer JR, Motzny S et al. Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using PhastSystem and immunofixation. J Lipid Res 1994;35:153-8.
27. Ohkubo I, Sahashi W, Namikuwa C, Tsukada K, Takeuchi T, Sasaki M. A procedure for large scale purification of human plasma amyloid P component. Clin Chim Acta 1986; 157:95-102.
28. Gianazza E. Isoelectric focusing as a tool for the investigation of posttranslational processing and chemical modifications of proteins. J Chromatogr A 1995;705:67-87.
29. Baltz ML, de Beer FC, Feinstein A, Pepys MB. Calcium-dependent aggregation of human serum amyloid P component. Biochim Biophys Acta 1982;701:229-36.
30. Haus H, Schlaak M. Conventional isoelectric focusing does not dissociate immune complexes. J Immunol Methods 1987;103:79-85.
31. Drake CG, Rozzo SJ, Vyse TJ, Kotzin BL. Absence of coding sequence polymorphism in the serum amyloid P component gene (Sap) in autoimmune New Zealand black mice. Mammal Genome 1996;7:466-7.